University of Miami, USA
Dr. Figueroa received her MD from Universidad del Salvador, School of Medicine in Buenos Aires, Argentina. She went on to train as a hematologist at the Institute for Hematological Research “Mariano Castex” from the National Academy of Medicine in Buenos Aires. In 2004 Dr. Figueroa joined Dr. Ari Melnick’s laboratory in New York. as a postdoctoral fellow, where she focused on the characterization of epigenetic deregulation in myeloid malignancies, particularly AML and MDS
In 2011 Dr. Figueroa started her independent career as an Assistant Professor at the University of Michigan Medical School, where she continued her work in the field of epigenetic regulation of normal and malignant hematopoiesis. In September 2016 she was recruited as Associate Professor to the University of Miami Miller School of Medicine, Dept. of Human Genetics. She serves as the Co-Leader Cancer Epigenetics Research Program and Assistant Director for Translational Research for the Sylvester Comprehensive Cancer Center. Dr. Figueroa has been the recipient of scholar awards from the American Society of Hematology, The Leukemia and Lymphoma Society and the Doris Duke Charitable Foundation.
The Figueroa lab studies the role of epigenetic modifications in transcriptional regulation during normal and malignant hematopoiesis. The lab’s focus is mainly on how changes in normal chromatin patterns occur during malignant transformation and how these changes may contribute to the leukemogenic process and disease phenotype. In addition, they seek to develop molecular biomarkers predictive of therapeutic response and clinical outcome.